Abstract Topics


Diagnosis

  • ​Cytomorphology
  • Flow cytometry
  • Genetic aberrations (cytogenetic, molecular)​

Epidemiology

​Health Economics & Outcome Research

  • ​​Cost of care
  • Patient-reported outcomes
  • Efficacy outcome measures

MDS Biology and Pathogenesis

  • ​​​Normal, MDS, and leukemic stem cells
  • Clonal diversity & evolution
  • Somatic mutations
  • Spliceosome machinery
  • Gene expression profiling
  • Epigenetic deregulation
  • Immune deregulation
  • Microenvironment and stem cell niche​

Nurses Program (For Poster Presentation Only)​

Prognosis

  • Prognostic factors of outcome and risk assessment
  • Predictive factors of response to treatment​

Singular Entities/Subtypes

  • ​​​MDS in childhood
  • Predisposition syndromes
  • MDS with ring sideroblasts
  • Chronic myelomonocytic leukemia and overlap syndromes (MDS/MPN)
  • MDS with deletion 5q
  • Treatment-related MDS​

Treatment

  • Current treatment options​
    • ​​Hypomethylating agents (azacitidine, decitabine)
    • Lenalidomide
    • Hematopoietic growth factors
  • New developments
  • Clinical trials
  • Allogeneic hematopoietic cell transplantation
  • Supportive care, including iron overload


Keep Me Updated